MEDS continues to grow faster than an already rapidly growing industry and has now established itself as a leading and profitable pharmacy operator. The company’s board is now being reinforced with two new members who will contribute relevant experience to the company's continued development.

"I am delighted that we are now strengthening the board with two highly competent members. Jina has a strong financial background and a deep understanding of the capital market, while Mia brings solid corporate governance experience from related sectors. I would also like to take this opportunity to thank Ingrid Jonasson Blank for her contributions over the past few years,’ says Christian W. Jansson, Chairman of the Board of MEDS.

Jina Zachrisson was Managing Director at Goldman Sachs until November 2024 and also has experience from Berenberg Bank and as an advisor in financial communications.

“MEDS is in an exciting phase with clear growth ambitions and a strong technological and operational foundation. I look forward to contributing my experience from the financial sector and supporting the company in its continued development,” says Jina Zachrisson.

Mia Arnhult has extensive experience of board work as a member of the board of directors of Logistea, KMC Properties, Devyser, Odd Molly, Bactiguard and Footway. Mia also has a background as an auditor.

“MEDS has all the prerequisites to scale its model further, and I look forward to being part of that journey,” says Mia Arnhult.

Christian W. Jansson, Björn Thorngren and Gunilla Spongh have been re-elected as members. Following the changes, the new board of directors consists of Christian W. Jansson (chairman), Björn Thorngren (co-founder and CEO), Gunilla Spongh, Mia Arnhult and Jina Zachrisson.